Menu

Stayble Science
Market Potential
Investor Relations
Upcoming Events
Our Team
How To Contact Us

Choose language

sv
en

Stayble Science
Market Potential
Investor Relations
Upcoming Events
Our Team
How To Contact Us

sv
en

Cancelled – Stayble will present at Mangold Insights Investerarfrukost 11 November

11November2020

Cancelled due to new guidelines regarding Covid-19.

Back

CONTACT

Arvid Hedvalls Backe 4,
SE-411 33 Gothenburg, Sweden
info@stayble.se

Menu

Stayble Science
Market Potential
Investor Relations
Upcoming Events
Our Team
How To Contact Us

STAYBLE THERAPEUTICS

Stayble Therapeutics is a Swedish life science company developing an injectable treatment against chronic low back pain triggered by disc degeneration. Stayble Therapeutics initiated a multinational clinical phase 2b trial in 2020.

We use cookies to improve the user experience on Stayble Therapeutics. Read more about Cookies

Approve